News
TN PTA appeals to Union Finance Minister for complete exemption of all life-saving medicines from GST: Peethaambaran Kunnathoor, Chennai Thursday, July 31, 2025, 08:00 Hrs [IST] T ...
VGGS commissioned in Gujarat: Dr. H G Koshia: Shardul Nautyal, Mumbai Thursday, July 31, 2025, 08:00 Hrs [IST] Out of the total 376 projects in ...
DBT engaged in various initiatives on alternatives to animal testing: Minister: Our Bureau, New Delhi Thursday, July 31, 2025, 08:00 Hrs [IST] Even as the Department of Biotechnol ...
SJM demands elimination of animal studies, more clarity on Biosimilar Guidelines: Gireesh Babu, New Delhi Thursday, July 31, 2025, 08:00 Hrs [IST] The Swadeshi Jagran Manch (SJM), ...
On July 24, India and the UK have signed a Free Trade Agreement in London in the presence of Indian Prime Minister Narendra Modi and UK premier Keir Starmer. The much-awaited Indo-UK FTA marks a ...
Agilent supports India’s global biopharma ambitions with state-of-the-art experience center in Hyderabad: Our Bureau, ...
Veranova appoints Thomas Rohrer as vice president of bioconjugation: Devens, Massachusetts Wednesday, July 30, 2025, 16:00 ...
US FDA approves PTC Therapeutics’ Sephience to treat children and adults living with phenylketonuria
US FDA approves PTC Therapeutics’ Sephience to treat children and adults living with phenylketonuria: Warren, New Jersey Wednesday, July 30, 2025, 15:00 Hrs [IST] PTC Therapeuti ...
Haleon partners with Indian Dental Association to inaugurate the first D20 International Symposium: Our Bureau, Mumbai Wednesday, July 30, 2025, 15:30 Hrs [IST] Haleon (erstwhile ...
Genethon gets UK MHRA nod to initiate pivotal phase 3 trial of GNT0004, a low-dose microdystrophin gene therapy for Duchenne muscular dystrophy: Paris, France Wednesday, July 30, ...
PCRM survey shows 91% of adults prefer a plant-based diet over injectable drugs for weight loss: Our Bureau, Bengaluru Wednesday, July 30, 2025, 17:45 Hrs [IST] Physicians Committ ...
Avidity Biosciences completes enrolment in HARBOR phase 3 trial of delpacibart etedesiran to treat myotonic dystrophy type 1: San Diego Wednesday, July 30, 2025, 10:00 Hrs [IST] A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results